Capital Flow Monitor · Sponsors · CIK 1649989
Outlook Therapeutics, Inc.
111 S. WOOD AVENUE, ISELIN, NJ, 08830 · 6096193990
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$5.0M
Sold
$0
% sold
0.0%
Investors
2
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-05-07 | D ·current | 506(b) | $5.0M | $0 | 0.0% | 2 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- Randy H. Thurman — Director, Iselin, NJ
- Yezan Haddadin — Director, Iselin, NJ
- Kurt J. Hilzinger — Director, Iselin, NJ
- Lawrence A. Kenyon — Executive Officer / Director, Iselin, NJ
- Faisal G. Sukhtian — Director, Iselin, NJ
- Andong Huang — Director, Iselin, NJ
- Gerd Auffarth — Director, Iselin, NJ
- Julian Gangolli — Director, Iselin, NJ
Placement agents
- H.c. Wainwright & Co., Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.